Viewing Study NCT06547203


Ignite Creation Date: 2025-12-24 @ 7:35 PM
Ignite Modification Date: 2026-02-21 @ 9:03 AM
Study NCT ID: NCT06547203
Status: RECRUITING
Last Update Posted: 2024-08-09
First Post: 2024-07-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cetuximab, Irinotecan, Toripalimab in RAS/BRAF Wild-type Ultraselected Right-sided Colorectal Cancer Study
Sponsor: Sun Yat-sen University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Colorectal Cancer Metastatic View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Metastatic colorectal cancer View
None RAS/BRAF wild type View
None Right-sided View
None Cetuximab View
None PD-1 inhibitor View